Addressing the Challenge of Common Chronic Diseases — A View from the FDA
Haider J. Warraich, Hilary D. Marston, Robert M. Califf
Abstract
Collaboration between the FDA and other stakeholders could improve the way in which evidence is generated and interventions are developed and implemented to help address common chronic diseases.
Topics & Concepts
Psychological interventionMedicineRisk analysis (engineering)Intensive care medicinePsychiatryChronic Disease Management StrategiesHealth Systems, Economic Evaluations, Quality of LifeObesity and Health Practices